Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma (ARTE)

  • Source: Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma

تفاصيل العنوان

×
Report

Assessment of Hypoxia Before Radioembolization Treatment With 18F-FMISO PET (ARTE-MISO)

  • Authors : Cigdem Soydal, Asc Prof

  • Source: Assessment of Hypoxia Before Radioembolization Treatment With 18F-FMISO PET

تفاصيل العنوان

×
Report

Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI (ARTE)

  • Authors : Josep Rodes-Cabau, MD

  • Source: Aspirin Versus Aspirin + ClopidogRel as Antithrombotic Treatment Following Transcatheter Aortic Valve Implantation With the Edwards Valve. A Randomized Study (the ARTE

تفاصيل العنوان

×
Report

Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE Trial (ARTE)

  • Source: Aspirin Versus Aspirin + ClopidogRel as Antithrombotic Treatment Following Transcatheter Aortic Valve Implantation With the Edwards SAPIEN XT Valve. A Randomized Pilot Study (the

تفاصيل العنوان

×
Report

RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected Patients (ARTE)

  • Source: A Pilot Randomized, Open Label Study to Evaluate Efficacy and Safety of the Combination of RAL+ATV/r in Comparison With TDF/FTC+ATV/r in HIV Infected Patients, Who Failed an Initial NNRTI Containing

تفاصيل العنوان

×
Report

Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma (ARTE)

  • Source: Avastin Plus Radiotherapy in Elderly Patients With GlioblastomaWirsching HG, Roelcke U, Weller J, Hundsberger T, Hottinger AF, von Moos R, Caparrotti F, Conen K, Remonda L, Roth P, Ochsenbein A,

تفاصيل العنوان

×
Report

CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients

  • Authors : Mahmoud Ramadan mohamed Elkazzaz, Clinical Researcher

  • Source: CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients

تفاصيل العنوان

×
Report

Recovery After Sugammadex(Propofol vs Sevoflurane) (Sugammadex2)

  • Source: Recovery After Sugammadex(TIVA Using Propofol vs Inhalation Anesthesia Using Sevoflurane)

تفاصيل العنوان

×